Agarwal S, Srinivasan B, Iyer G, Pandey S, Agarwal M, Dhiman R
Indian J Ophthalmol. 2023; 72(1):44-50.
PMID: 38131568
PMC: 10841783.
DOI: 10.4103/IJO.IJO_1022_23.
Me R, Gao N, Zhang Y, Lee P, Wang J, Liu T
J Immunol. 2021; 207(11):2868-2877.
PMID: 34686582
PMC: 8612993.
DOI: 10.4049/jimmunol.2001246.
Ung L, Chodosh J
Ocul Surf. 2021; 28:378-400.
PMID: 34461290
PMC: 10721114.
DOI: 10.1016/j.jtos.2021.08.013.
Ung L, Chodosh J
Exp Eye Res. 2021; 209:108647.
PMID: 34097906
PMC: 8595513.
DOI: 10.1016/j.exer.2021.108647.
Me R, Gao N, Dai C, Yu F
J Immunol. 2019; 204(1):169-179.
PMID: 31767781
PMC: 6920547.
DOI: 10.4049/jimmunol.1900736.
Bacterial keratitis: perspective on epidemiology, clinico-pathogenesis, diagnosis and treatment.
Al-Mujaini A, Al-Kharusi N, Thakral A, Wali U
Sultan Qaboos Univ Med J. 2011; 9(2):184-95.
PMID: 21509299
PMC: 3074777.
Assessment of Streptococcus pneumoniae capsule in conjunctivitis and keratitis in vivo neuraminidase activity increases in nonencapsulated pneumococci following conjunctival infection.
Norcross E, Tullos N, Taylor S, Sanders M, Marquart M
Curr Eye Res. 2010; 35(9):787-98.
PMID: 20795860
PMC: 2997481.
DOI: 10.3109/02713683.2010.492462.
Proinflammatory cytokine deficiency and pathogenesis of Pseudomonas aeruginosa keratitis in aged mice.
Hobden J, Masinick S, Barrett R, Hazlett L
Infect Immun. 1997; 65(7):2754-8.
PMID: 9199446
PMC: 175388.
DOI: 10.1128/iai.65.7.2754-2758.1997.
Relationship between cytotoxicity and corneal epithelial cell invasion by clinical isolates of Pseudomonas aeruginosa.
Fleiszig S, Zaidi T, Preston M, Grout M, Evans D, Pier G
Infect Immun. 1996; 64(6):2288-94.
PMID: 8675339
PMC: 174068.
DOI: 10.1128/iai.64.6.2288-2294.1996.
Efficacy of topical gentamicin treatment after 193-nm photorefractive keratectomy in an experimental Pseudomonas keratitis model.
Frucht-Pery J, Golan G, Hemo I, Zauberman H, Shapiro M
Graefes Arch Clin Exp Ophthalmol. 1995; 233(8):532-4.
PMID: 8537030
DOI: 10.1007/BF00183436.
Changes in rabbit corneal epithelial membrane permeability caused by locally applied Pseudomonas aeruginosa cytotoxin: a microfluorometric examination in vivo.
LUTZ F, Kaszli F, Bach P, Thaer A
Graefes Arch Clin Exp Ophthalmol. 1994; 232(6):373-8.
PMID: 8082846
DOI: 10.1007/BF00175990.
Pharmacokinetic considerations in the treatment of bacterial keratitis.
Callegan M, OCallaghan R, Hill J
Clin Pharmacokinet. 1994; 27(2):129-49.
PMID: 7955776
DOI: 10.2165/00003088-199427020-00005.
Antibiotic therapy for ocular infection.
Snyder R, Glasser D
West J Med. 1994; 161(6):579-84.
PMID: 7856158
PMC: 1022739.
Norfloxacin and silver norfloxacin in the treatment of Pseudomonas corneal ulcer in the rabbit.
DARRELL R, Modak S, FOX Jr C
Trans Am Ophthalmol Soc. 1984; 82:75-91.
PMID: 6242083
PMC: 1298655.
Iontophoretic application of tobramycin to uninfected and Pseudomonas aeruginosa-infected rabbit corneas.
Hobden J, Rootman D, OCallaghan R, Hill J
Antimicrob Agents Chemother. 1988; 32(7):978-81.
PMID: 3142344
PMC: 172328.
DOI: 10.1128/AAC.32.7.978.